SCHEMBL27754759

SCHEMBL27754759

NC(=O)C(N)CC(=O)NCc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.54
KMT2A Q03164 4/20 0.54
HPGD P15428 4/20 0.54
MEN1 O00255 3/20 0.54
SLC1A1 P43005 1/20 0.54
DPP4 P27487 1/20 0.51
DPP8 Q6V1X1 1/20 0.51
TSHR P16473 2/20 0.50
MCL1 Q07820 1/20 0.50
ALDH1A1 P00352 3/20 0.49
MAPT P10636 1/20 0.49
HTT P42858 2/20 0.49
LMNA P02545 2/20 0.49
CYP1A2 P05177 1/20 0.49
CYP2D6 P10635 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14381152 1.00 GAA (0.54) GAAKMT2AHPGDMEN1SLC1A1
SCHEMBL1768744 0.88 SLC1A1 (0.67) GAAKMT2AHPGDMEN1SLC1A1
SCHEMBL1768747 0.88 SLC1A1 (0.67) GAAKMT2AHPGDMEN1SLC1A1
SCHEMBL14381160 0.84 SLC1A1 (0.66) GAAKMT2AHPGDMEN1SLC1A1
SCHEMBL28279974 0.83 GAA (0.58) GAAKMT2AHPGDMEN1SLC1A1
SCHEMBL6432230 0.82 HPGD (0.60) GAAKMT2AHPGDMEN1ALDH1A1
SCHEMBL4788083 0.82 HPGD (0.60) GAAKMT2AHPGDMEN1ALDH1A1
SCHEMBL15514213 0.81 KMT2A (0.63) GAAKMT2AHPGDMEN1MCL1
SCHEMBL14005782 0.80 ALDH1A1 (0.53) GAAKMT2AHPGDMEN1SLC1A1
SCHEMBL22636418 0.80 GAA (0.54) GAAKMT2AHPGDMEN1SLC1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101400699-A Human glucagon-like-peptide-1 modulators and their use in the treatment of diabetes and related conditions BRISTOL MYERS SQUIBB CO (US) 2009-04-01 CN claimed
CN-101400699-A Human glucagon-like-peptide-1 modulators and their use in the treatment of diabetes and related conditions BRISTOL MYERS SQUIBB CO (US) 2009-04-01 CN disclosed